The vaccine not only prevents severe disease, but also effectively blocks viral transmission in animal models, offering a promising strategy for pandemic preparedness against future coronavirus threats. A research team at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has developed a novel live-attenuated vaccine candidate, cb1, capable of generating broad immunity against a wide range of beta-coronaviruses with a single intranasal dose. The vaccine not on

New correspondance from Dr. Vijaykrishna Dhanasekaran o n the New England Journal of Medicine , this correspondance investigates the resurgence of highly pathogenic avian influenza (HPAI) A(H5N1) virus infections in Cambodia after nearly a decade of no reported human cases. To the Editor: After a decade of no reported human cases, Cambodia faces a resurgence of highly pathogenic avian influenza (HPAI) A(H5N1) virus infections, with an overall mortality of 38%. Cases have occ

New publication from HKU-Pasteur's Carolyn Cohen and Sophie Valkenburg with the Peter Doherty Institute for Infection and Immunity...